BCDA
Income statement / Annual
Last year (2024), BioCardia, Inc.'s total revenue was $58,000.00,
a decrease of 87.84% from the previous year.
In 2024, BioCardia, Inc.'s net income was -$7.95 M.
See BioCardia, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$58,000.00 |
$477,000.00 |
$1.35 M |
$1.02 M |
$145,000.00 |
$710,000.00 |
$625,000.00 |
$479,000.00 |
$576,000.00 |
$517,000.00 |
| Cost of Revenue |
$0.00
|
$7.73 M
|
$11.90 M
|
$640,000.00
|
$4,000.00
|
$358,000.00
|
$517,000.00
|
$690,000.00
|
$746,000.00
|
$0.00
|
| Gross Profit |
$58,000.00
|
-$7.25 M
|
-$10.55 M
|
$375,000.00
|
$141,000.00
|
$352,000.00
|
$108,000.00
|
-$211,000.00
|
-$170,000.00
|
$517,000.00
|
| Gross Profit Ratio |
1
|
-15.2
|
-7.8
|
0.37
|
0.97
|
0.5
|
0.17
|
-0.44
|
-0.3
|
1
|
| Research and Development Expenses |
$4.39 M
|
$7.73 M
|
$8.83 M
|
$8.56 M
|
$9.81 M
|
$8.56 M
|
$8.45 M
|
$5.80 M
|
$3.33 M
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.73 M
|
$0.00
|
$198,000.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.66 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.67 M
|
$4.40 M
|
$4.42 M
|
$5.09 M
|
$5.86 M
|
$6.00 M
|
$5.76 M
|
$6.40 M
|
$4.11 M
|
$198,000.00
|
| Other Expenses |
$0.00
|
$0.00
|
-$6,000.00
|
-$2,000.00
|
-$2,000.00
|
-$2,000.00
|
-$3,000.00
|
$2,000.00
|
-$2,000.00
|
$0.00
|
| Operating Expenses |
$8.06 M
|
$12.12 M
|
$13.25 M
|
$13.65 M
|
$15.67 M
|
$14.57 M
|
$14.21 M
|
$12.19 M
|
$7.44 M
|
$198,000.00
|
| Cost And Expenses |
$8.06 M
|
$12.12 M
|
$13.25 M
|
$13.65 M
|
$15.67 M
|
$14.92 M
|
$14.73 M
|
$12.88 M
|
$8.18 M
|
$198,000.00
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$9,000.00
|
$21,000.00
|
$87,000.00
|
$118,000.00
|
$95,000.00
|
$0.00
|
$3,000.00
|
| Interest Expense |
$0.00
|
$0.00
|
$6,000.00
|
$0.00
|
$3,000.00
|
$112,000.00
|
$0.00
|
$95,000.00
|
$1.74 M
|
$3,000.00
|
| Depreciation & Amortization |
$67,000.00
|
$84,000.00
|
$377,000.00
|
$640,000.00
|
$566,000.00
|
$551,000.00
|
$203,000.00
|
$78,000.00
|
$39,000.00
|
$0.00
|
| EBITDA |
-$7.93 M |
-$11.56 M |
-$11.82 M |
-$12.57 M |
-$14.44 M |
-$14.05 M |
-$13.90 M |
-$12.23 M |
-$8.54 M |
$319,000.00 |
| EBITDA Ratio |
-136.79
|
-24.23
|
-8.74
|
-12.38
|
-99.55
|
-19.78
|
-22.24
|
-25.53
|
-14.82
|
0.62
|
| Operating Income Ratio |
-137.95
|
-24.41
|
-8.8
|
-12.44
|
-107.1
|
-20.02
|
-22.56
|
-25.9
|
-13.21
|
0.62
|
| Total Other Income/Expenses Net |
$55,000.00
|
$73,000.00
|
-$6,000.00
|
$7,000.00
|
$525,000.00
|
-$496,000.00
|
$115,000.00
|
$97,000.00
|
-$2.70 M
|
$3,000.00
|
| Income Before Tax |
-$7.95 M
|
-$11.57 M
|
-$11.91 M
|
-$12.62 M
|
-$15.00 M
|
-$14.71 M
|
-$13.99 M
|
-$12.31 M
|
-$10.31 M
|
$322,000.00
|
| Income Before Tax Ratio |
-137
|
-24.26
|
-8.81
|
-12.44
|
-103.48
|
-20.72
|
-22.38
|
-25.7
|
-17.9
|
0.62
|
| Income Tax Expense |
$0.00
|
$0.00
|
$6,000.00
|
-$2,000.00
|
$1,000.00
|
$110,000.00
|
-$115,000.00
|
-$192,000.00
|
$5.40 M
|
-$6,000.00
|
| Net Income |
-$7.95 M
|
-$11.57 M
|
-$11.91 M
|
-$12.62 M
|
-$15.01 M
|
-$14.82 M
|
-$13.87 M
|
-$12.31 M
|
-$10.31 M
|
$322,000.00
|
| Net Income Ratio |
-137
|
-24.26
|
-8.81
|
-12.43
|
-103.48
|
-20.87
|
-22.2
|
-25.7
|
-17.9
|
0.62
|
| EPS |
-2.9 |
-8.19 |
-10.08 |
-11.19 |
-22.24 |
-39.38 |
-48.8 |
-43.54 |
-166.33 |
27.86 |
| EPS Diluted |
-0.0029 |
-8.19 |
-10.08 |
-11.19 |
-22.24 |
-39.38 |
-48.8 |
-43.54 |
-166.33 |
27.86 |
| Weighted Average Shares Out |
$2.74 M
|
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674,579.00
|
$376,289.00
|
$284,279.00
|
$282,671.00
|
$61,987.00
|
$11,558.00
|
| Weighted Average Shares Out Diluted |
$2.74 B
|
$1.41 M
|
$1.18 M
|
$1.13 M
|
$674,579.00
|
$376,289.00
|
$284,279.00
|
$282,671.00
|
$61,987.00
|
$11,558.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
